A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment

International Clinical Psychopharmacology

Volumn 30, Issue 3, 2015, Pages 167-174

  Naylor, Jennifer C ^a,b,c   Kilts, Jason D ^a,b,c   Bradford, Daniel W ^a,b,c   Strauss, Jennifer L ^a,b,c   Capehart, Bruce P ^a,b   Szabo, Steven T ^a,b,c   Smith, Karen D ^a,b,c   Dunn, Charlotte E ^a,c   Conner, Kathryn M ^b   Davidson, Jonathan R T ^b   Wagner, Henry Ryan ^a,b,c   Hamer, Robert M ^d,e   Marx, Christine E ^a,b,c  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Education and Clinical Center   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e IL   (United States)

Author keywords

Antipsychotic; Anxiety; Aripiprazole; Clinical trial; Controlled; Depression; Post traumatic stress disorder; Psychosis; Randomized; Veterans

Indexed keywords

ARIPIPRAZOLE; PLACEBO; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ADULT; AGED; ARMY; ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; CONTROLLED STUDY; DEPRESSION ASSESSMENT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; POSTTRAUMATIC STRESS DISORDER; POSTTRAUMATIC STRESS DISORDER SCALE CHECKLIST; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; VETERAN; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; MIDDLE AGED; PILOT STUDY; PSYCHOLOGY; PUBLIC HOSPITAL; SOLDIER; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PILOT PROJECTS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; VETERANS; YOUNG ADULT;

EID: 84927178285     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0000000000000061     Document Type: Article

References (35)

1. Ahearn EP, Mussey M, Johnson C, Krohn A, Krahn D (2006). Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week openlabel study. Int Clin Psychopharmacol 21:29-33.
2. Bartzokis G, Lu PH, Turner J, Mintz J, Saunders CS (2005). Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry 57:474-479.
3. Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I (2009). Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 33:169-180.
4. Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, Khan A (2007). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68:843-853.
5. Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, et al. (2009). Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to anti-depressants. CNS Spectr 14:197-206.
6. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. (1995). The development of a clinician-administered PTSD Scale. J Trauma Stress 8:75-90.
7. Brady K, Pearlstein T, Asnis GM, Baker D, Rothbaum B, Sikes CR, Farfel GM (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA 283:1837-1844.
8. Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR (2001). Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol 16:197-203.
9. Carey P, Suliman S, Ganesan K, Seedat S, Stein DJ (2012). Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol 27:386-391.
10. Connor KM, Davidson JR (2003). Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 18:76-82.
11. Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MA, Perantie DC, et al. (2014). Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study. Psychiatry Res 221:231-239.
12. Geracioti TD Jr, Jefferson-Wilson L, Strawn JR, Baker DG, Dashevsky BA, Horn PS, Ekhator NN (2013). Effect of traumatic imagery on cerebrospinal fluid dopamine and serotonin metabolites in posttraumatic stress disorder. J Psychiatr Res 47:995-998.
13. Hamner MB, Deitsch SE, Brodrick PS, Ulmer HG, Lorberbaum JP (2003). Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol 23:15-20.
14. Heppner PS, Crawford EF, Haji UA, Afari N, Hauger RL, Dashevsky BA, et al. (2009). The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med 7:1.
15. Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW (2002). Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 63:763-771.
16. Keck PE Jr, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G. Aripiprazole Study Group (2003). A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160:1651-1658.
17. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048-1060.
18. Kozaric-Kovacic D, Pivac N (2007). Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Int J Neuropsychopharmacol 10:253-261.
19. Kozarić-Kovacić D, Pivac N, Mück-Seler D, Rothbaum BO (2005). Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry 66:922-927.
20. Krystal JH, Rosenheck RA, Cramer JA, Vessicchio JC, Jones KM, Vertrees JE, et al. Veterans Affairs Cooperative Study No. 504 Group (2011). Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial. JAMA 306:493-502.
21. Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, et al. (2008). The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 28:156-165.
22. Marshall RD, Beebe KL, Oldham M, Zaninelli R (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebocontrolled study. Am J Psychiatry 158:1982-1988.
23. Mello MF, Costa MC, Schoedl AF, Fiks JP (2008). Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial. Rev Bras Psiquiatr 30:358-361.
24. Monnelly EP, Ciraulo DA, Knapp C, Keane T (2003). Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol 23:193-196.
25. Padala PR, Madison J, Monnahan M, Marcil W, Price P, Ramaswamy S, et al. (2006). Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol 21:275-280.
26. Petty F, Brannan S, Casada J, Davis LL, Gajewski V, Kramer GL, et al. (2001). Olanzapine treatment for post-traumatic stress disorder: an open-label study. Int Clin Psychopharmacol 16:331-337.
27. Pivac N, Kozarić-Kovacić D (2006). Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features. Croat Med J 47:440-451.
28. Pivac N, Kozaric-Kovacic D, Muck-Seler D (2004). Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder. Psychopharmacology (Berl) 175:451-456.
29. Reich DB, Winternitz S, Hennen J, Watts T, Stanculescu C (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry 65:1601-1606.
30. Robert S, Hamner MB, Durkalski VL, Brown MW, Ulmer HG (2009). An openlabel assessment of aripiprazole in the treatment of PTSD. Psychopharmacol Bull 42:69-80.
31. Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH (2008). Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry 69:520-525.
32. Simon JS, Nemeroff CB (2005). Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. J Clin Psychiatry 66 :1216-1220.
33. Stein MB, Kline NA, Matloff JL (2002). Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 159:1777-1779.
34. Villarreal G, Calais LA, Cañive JM, Lundy SL, Pickard J, Toney G (2007). Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial. Psychopharmacol Bull 40:6-18.
35. Youssef NA, Marx CE, Bradford DW, Zinn S, Hertzberg MA, Kilts JD, et al. (2012). An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to anti-depressants. Int Clin Psychopharmacol 27:191-196.